ERBB2 and breast carcinoma: Of the five major breast cancer subtypes represented in the Prediction Analysis of Microarrays (PAM50) subtyping (Parker et al, 2009), the one overexpressing the RTK called HER2 and the less prevalent, the basal‐like subtype are considered highly aggressive (Perou et al, 2000).